Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance
Serena Spudich, … , Alyssa Vecchio, John W. Mellors
Serena Spudich, … , Alyssa Vecchio, John W. Mellors
Published July 15, 2019
Citation Information: J Clin Invest. 2019;129(8):3339-3346. https://doi.org/10.1172/JCI127413.
View: Text | PDF
Clinical Research and Public Health AIDS/HIV Immunology Article has an altmetric score of 222

Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance

  • Text
  • PDF
Abstract

BACKGROUND Persistence of HIV in sanctuary sites despite antiretroviral therapy (ART) presents a barrier to HIV remission and may affect neurocognitive function. We assessed HIV persistence in cerebrospinal fluid (CSF) and associations with inflammation and neurocognitive performance during long-term ART.METHODS Participants enrolled in the AIDS Clinical Trials Group (ACTG) HIV Reservoirs Cohort Study (A5321) underwent concurrent lumbar puncture, phlebotomy, and neurocognitive assessment. Cell-associated HIV DNA and HIV RNA (CA-DNA, CA-RNA) were measured by quantitative PCR (qPCR). in peripheral blood mononuclear cells (PBMCs) and in cell pellets from CSF. In CSF supernatant and blood plasma, cell-free HIV RNA was quantified by qPCR with single copy sensitivity, and inflammatory biomarkers were measured by enzyme immunoassay.RESULTS Sixty-nine participants (97% male, median age 50 years, CD4 696 cells/mm3, plasma HIV RNA <100 copies/mL) were assessed after a median 8.6 years of ART. In CSF, cell-free RNA was detected in 4%, CA-RNA in 9%, and CA-DNA in 48% of participants (median level 2.1 copies/103 cells). Detection of cell-free CSF HIV RNA was associated with higher plasma HIV RNA (P = 0.007). CSF inflammatory biomarkers did not correlate with HIV persistence measures. Detection of CSF CA-DNA HIV was associated with worse neurocognitive outcomes including global deficit score (P = 0.005), even after adjusting for age and nadir CD4 count.CONCLUSION HIV-infected cells persist in CSF in almost half of individuals on long-term ART, and their detection is associated with poorer neurocognitive performance.FUNDING This observational study, AIDS Clinical Trials Group (ACTG) HIV Reservoirs Cohort Study (A5321), was supported by the National Institutes of Health (NIAID and NIMH).

Authors

Serena Spudich, Kevin R. Robertson, Ronald J. Bosch, Rajesh T. Gandhi, Joshua C. Cyktor, Hanna Mar, Bernard J. Macatangay, Christina M. Lalama, Charles Rinaldo, Ann C. Collier, Catherine Godfrey, Joseph J. Eron, Deborah McMahon, Jana L. Jacobs, Dianna Koontz, Evelyn Hogg, Alyssa Vecchio, John W. Mellors

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 Total
Citations: 9 8 10 16 15 13 5 76
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (76)

Title and authors Publication Year
Inflammatory responses revealed through HIV infection of microglia-containing cerebral organoids
Narasipura SD, Zayas JP, Ash MK, Reyes AF, Shull T, Gambut S, Szczerkowski JL, McKee C, Schneider JR, Lorenzo-Redondo R, Al-Harthi L, Mamede JI
Journal of Neuroinflammation 2025
HIV, smoking, and the brain: a convergence of neurotoxicities
Orlinick BL, Farhadian SF
AIDS Research and Therapy 2025
HIV Cerebrospinal Fluid Escape: Interventions for the Management, Current Evidence and Future Perspectives
Kelly SH, Nightingale S, Gupta RK, Collier DA
Tropical Medicine and Infectious Disease 2025
Longitudinal CNS and systemic T-lymphocyte and monocyte activation before and after antiretroviral therapy beginning in primary HIV infection
Chan P, Li X, Li F, Emu B, Price RW, Spudich S
Frontiers in Immunology 2025
The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognition
Trunfio M, Scutari R, Fox V, Vuaran E, Dastgheyb RM, Fini V, Granaglia A, Balbo F, Tortarolo D, Bonora S, Perno CF, Di Perri G, Alteri C, Calcagno A
bioRxiv 2025
Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir
Pascoe RD, Kim Y, Rhodes A, Ong J, Tumpach C, Gubser C, Chang JJ, McMahon JH, Lewin SR, Rasmussen TA
Journal of Virology 2025
A longitudinal analysis of neurocognitive profiles in South African women with HIV
Van der Watt A, Spies G, Seedat S
AIDS care 2025
Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches
Jia F(, Brew BJ
Current Opinion in HIV and AIDS 2025
Pharmacokinetic Approaches to Standardize Antiviral Exposure in Cerebrospinal Fluid
Avedissian SN, Mu Y, McCarthy C, Bosch RJ, Spudich S, Gandhi RT, McMahon DK, Eron JJ, Mellors JW, Liu J, Podany AT, Fletcher CV
Pharmacotherapy 2025
Rare HIV-1 infected T cell clones persist across cerebrospinal fluid and blood despite ART
Meng Wang, Jennifer Yoon, Hailey Reisert, Bibhuprasad Das, Jennifer Chiarella, Elias Halvas, John Mellors, Alina Pang, Lydia Barakat, Margaret Fikrig, Joshua Cyktor, Yuval Kluger, Serena Spudich, Michael Corley, Shelli Farhadian
JCI Insight 2024
Neurosymptomatic HIV-1 CSF escape is associated with replication in CNS CD4+ T cells and inflammation
Laura Kincer, Ameet Dravid, Mattia Trunfio, Andrea Calcagno, Shuntai Zhou, Riccardo Vercesi, Serena Spudich, Magnus Gisslen, Richard Price, Paola Cinque, Sarah Joseph
Journal of Clinical Investigation 2024
Microglial- neuronal crosstalk in chronic viral infection through mTOR, SPP1/OPN and inflammasome pathway signaling
Argandona Lopez C, Brown AM
Frontiers in immunology 2024
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy
Wagner TA, Tierney C, Huang S, Nichols S, Malee KM, Montañez NA, Coletti A, Spiegel HM, Krotje C, Bone F, Wilkins M, Abuogi L, Purswani M, Bearden A, Wiznia A, Agwu A, Chadwick EG, Richman D, Gandhi M, Mehta P, Macatangay B, Spector SA, Spudich S, Persaud D, Chahroudi A
AIDS 2024
The identification of intact HIV proviral DNA from human cerebrospinal fluid
Zhang Z, Reece MD, Roa S, Tyor W, Franklin DR, Letendre SL, Marconi VC, Anderson AM, Gavegnano C
Neurotherapeutics 2024
HIV-1 and methamphetamine co-treatment in primary human astrocytes: TAARgeting ER/UPR dysfunction.
Proulx JM, Park IW, Borgmann K
NeuroImmune pharmacology and therapeutics 2024
The Association Between Serum Mature and Precursor Brain-Derived Neurotrophic Factor and Neurocognitive Function in People With Human Immunodeficiency Virus: A Longitudinal Study
Michael HU, Rapulana AM, Smit T, Xulu N, Danaviah S, Ramlall S, Oosthuizen F
Open Forum Infectious Diseases 2024
Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection.
Hu Z, Cinque P, Dravid A, Hagberg L, Yilmaz A, Zetterberg H, Fuchs D, Gostner J, Blennow K, Spudich SS, Kincer L, Zhou S, Joseph SB, Swanstrom R, Price RW, Gisslén M
PLoS pathogens 2024
Brain microglia are a persistent HIV reservoir despite durable antiretroviral therapy
Yuyang Tang, Antoine Chaillon, Sara Gianella, Lilly Wong, Dajiang Li, Theresa Simermeyer, Magali Porrachia, Caroline Ignacio, Brendon Woodworth, Daniel Zhong, Jiayi Du, Eduardo Polina, Jenn Kirchherr, Brigitte Allard, Matthew Clohosey, Matt Moeser, Amy Sondgeroth, Gregory Whitehill, Vidisha Singh, Amir Dashti, Davey Smith, Joseph Eron, Katherine Bar, Ann Chahroudi, Sarah Joseph, Nancie Archin, David M. Margolis, Guochun Jiang
Journal of Clinical Investigation 2023
HIV infection of non-classical cells in the brain
Wahl A, Al-Harthi L
Retrovirology 2023
Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study
Wan Z, Tao R, Hui J, Liu X, Peng X, Guo Y, Zhu X, Huang Y, Zhu B
Journal of Neuroinflammation 2023
Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology
Joseph SB, Gianella S, Burdo TH, Cinque P, Gisslen M, Letendre S, Nath A, Morgello S, Ndhlovu LC, Spudich S
The Journal of Infectious Diseases 2023
Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques.
Byrnes SJ, Busman-Sahay K, Angelovich TA, Younger S, Taylor-Brill S, Nekorchuk M, Bondoc S, Dannay R, Terry M, Cochrane CR, Jenkins TA, Roche M, Deleage C, Bosinger SE, Paiardini M, Brew BJ, Estes JD, Churchill MJ
PLoS pathogens 2023
Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy
Gabuzda D, Yin J, Misra V, Chettimada S, Gelman BB
Viruses 2023
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus
Letendre SL, Chen H, McKhann A, Roa J, Vecchio A, Daar ES, Berzins B, Hunt PW, Marra CM, Campbell TB, Coombs RW, Ma Q, Swaminathan S, Macatangay BJ, Morse GD, Miller T, Rusin D, Greninger AL, Ha B, Alston-Smith B, Robertson K, Paul R, Spudich S
Clinical Infectious Diseases 2023
CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy
Guha D, Misra V, Yin J, Gabuzda D
Viruses 2023
Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus
Yucha R, Litchford ML, Fish CS, Yaffe ZA, Richardson BA, Maleche-Obimbo E, John-Stewart G, Wamalwa D, Overbaugh J, Lehman DA
Viruses 2023
Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management.
Ellis RJ, Marquine MJ, Kaul M, Fields JA, Schlachetzki JCM
Nature reviews. Neurology 2023
HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART
Shelli F. Farhadian, Ofir Lindenbaum, Jun Zhao, Michael J Corley, Yunju Im, Hannah L Walsh, Alyssa Vecchio, Rolando Garcia-Milian, Jennifer Chiarella, Michelle Chintanaphol, Rachela Calvi, Guilin Wang, Lishomwa c. Ndhlovu, Jennifer Yoon, Diane G. Trotta, Shuangge Ma, Yuval Kluger, Serena Spudich
JCI Insight 2022
Intact HIV proviruses persist in the central nervous system despite viral suppression with antiretroviral therapy
Catherine Cochrane, Thomas Angelovich, Aleks Guanizo, Gemma Trollope, Lachlan Senior, Emma Wanicek, Janna Eddine, Matthew Gartner, Emily Waring, Jacob Estes, Bruce Brew, Sharon Lewin, Michael Roche, Melissa Churchill
Annals of Neurology 2022
Senotherapeutics in Cancer and HIV
L Sánchez-Díaz, A Espinosa-Sánchez, J Blanco, A Carnero
Cells 2022
HIV Compartmentalization in the CNS and Its Impact in Treatment Outcomes and Cure Strategies
P Chan, S Spudich
Current HIV/AIDS Reports 2022
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy
Jennifer Zerbato, Anchalee Avihingsanon, Kasha Singh, Wei Zhao, Claire Deleage, Elias Rosen, Mackenzie Cottrell, Ajantha Rhodes, Ashanti Dantanarayana, Carolin Tumpach, Surekha Tennakoon, Megan Crane, David Price, Sabine Braat, Hugh Mason, Michael Roche, Angela Kashuba, Peter Revill, Jennifer Audsley, Sharon Lewin
EBioMedicine 2022
A Non-Canonical Role for IRE1α Links ER and Mitochondria as Key Regulators of Astrocyte Dysfunction: Implications in Methamphetamine use and HIV-Associated Neurocognitive Disorders
Proulx J, Stacy S, Park IW, Borgmann K
Frontiers in neuroscience 2022
Cytomegalovirus: 40 years and still the major viral cofactor in HIV infection
Rinaldo CR
AIDS 2022
Methamphetamine induces transcriptional changes in cultured HIV-infected mature monocytes that may contribute to HIV neuropathogenesis
Chilunda V, Weiselberg J, Martinez-Meza S, Mhamilawa LE, Cheney L, Berman JW
Frontiers in immunology 2022
No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART.
Ward AR, Thomas AS, Stevenson EM, Huang SH, Keating SM, Gandhi RT, McMahon DK, Bosch RJ, Macatangay BJ, Cyktor JC, Eron JJ, Mellors JW, Jones RB
AIDS 2022
Effects of Morphine on Gp120-induced Neuroinflammation Under Immunocompetent Vs. Immunodeficient Conditions.
Canonico D, Casale S, Look T, Cao L
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2022
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program.
Riggs PK, Chaillon A, Jiang G, Letendre SL, Tang Y, Taylor J, Kaytes A, Smith DM, Dubé K, Gianella S
Current HIV/AIDS Reports 2022
Molecular neuroimaging of inflammation in HIV.
Alagaratnam J, Winston A
Clinical & Experimental Immunology 2022
A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment
Scanlan A, Zhang Z, Koneru R, Reece M, Gavegnano C, Anderson AM, Tyor W
Microorganisms 2022
Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections.
Reece MD, Song C, Hancock SC, Pereira Ribeiro S, Kulpa DA, Gavegnano C
Frontiers in immunology 2022
Shock and kill within the CNS: A promising HIV eradication approach?
Nühn MM, Gumbs SB, Buchholtz NV, Jannink LM, Gharu L, de Witte LD, Wensing AM, Lewin SR, Nijhuis M, Symons J
Journal of leukocyte biology 2022
Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury
Suzuki K, Zaunders J, Gates TM, Levert A, Butterly S, Liu Z, Ishida T, Palmer S, Rae CD, Jugé L, Cysique LA, Brew BJ
Proceedings of the National Academy of Sciences 2022
Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy
M Scherpenisse, NA Kootstra, M Bakker, B Berkhout, AO Pasternak, TE Smithgall
mBio 2021
Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators
MD Reece, RR Taylor, C Song, C Gavegnano
Frontiers in immunology 2021
Co-receptor signaling in the pathogenesis of neuroHIV
EA Nickoloff-Bybel, L Festa, O Meucci, PJ Gaskill
Retrovirology 2021
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
SG Deeks, N Archin, P Cannon, S Collins, RB Jones, MA de Jong, O Lambotte, R Lamplough, T Ndungu, J Sugarman, CT Tiemessen, L Vandekerckhove, SR Lewin, S Deeks, S Lewin, M de Jong, Z Ndhlovu, N Chomont, Z Brumme, K Deng, L Jasenosky, R Jefferys, A Orta-Resendiz, F Mardarelli, M Nijhuis, K Bar, B Howell, A Schneider, G Turk, R Nabatanzi, J Blankson, JV Garcia, M Paiardini, J van Lunzen, C Antoniadi, FH Côrtes, S Valente, OS Søgaard, RS Diaz, M Ott, R Dunham, S Schwarze, SP Patrigeon, J Nabukenya, M Caskey, B Mothe, FS Wang, S Fidler, D SenGupta, S Dressler, M Matoga, HP Kiem, P Tebas, C Kityo, B Dropulic, M Louella, KT Das, D Persaud, A Chahroudi, K Luzuriaga, T Puthanakit, J Safrit, G Masheto, K Dubé, J Power, J Salzwedel, U Likhitwonnawut, J Taylor, OL Nuh, K Dong, EN Kankaka
Nature Medicine 2021
T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy
G Lustig, S Cele, F Karim, A Derache, A Ngoepe, K Khan, BI Gosnell, MY Moosa, N Ntshuba, S Marais, PM Jeena, K Govender, J Adamson, H Kløverpris, RK Gupta, R Harrichandparsad, VB Patel, A Sigal, R Swanstrom
PLoS pathogens 2021
Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy
AM Anderson, S Kundu, B Tang, F Vaida, O Okwuegbuna, D McClernon, M Cherner, R Deutsch, D Cookson, M Crescini, I Grant, H Zetterberg, K Blennow, M Gisslen, RJ Ellis, SL Letendre
Journal of Neuroimmunology 2021
A streamlined clinical metagenomic sequencing protocol for rapid pathogen identification
X Jia, L Hu, M Wu, Y Ling, W Wang, H Lu, Z Yuan, Z Yi, X Zhang
Scientific Reports 2021
Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression
M Gisslen, SM Keating, S Spudich, V Arechiga, S Stephenson, H Zetterberg, CD Germanio, K Blennow, D Fuchs, L Hagberg, PJ Norris, J Peterson, BL Shacklett, CT Yiannoutsos, RW Price, A Calcagno
PloS one 2021
Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy
JJ Weiss, R Calvi, M Naganawa, T Toyonaga, SF Farhadian, M Chintanaphol, J Chiarella, MQ Zheng, J Ropchan, Y Huang, RH Pietrzak, RE Carson, S Spudich
Clinical Infectious Diseases 2021
Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection
G Mak, JJ Zaunders, M Bailey, N Seddiki, G Rogers, L Leong, TG Phan, AD Kelleher, KK Koelsch, MA Boyd, M Danta
Frontiers in immunology 2021
Intramuscular and subcutaneous administration of antiretroviral drugs, compared with oral, enhances delivery to lymphoid tissues in BALB/c mice
SR Dyavar, S Kumar, N Gautam, AT Podany, LC Winchester, JA Weinhold, TM Mykris, P Nallasamy, Y Alnouti, CV Fletcher
Journal of Antimicrobial Chemotherapy 2021
Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage
AR Denton, CF Mactutus, AU Lateef, SB Harrod, RM Booze
Journal of Neurovirology 2021
Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study
AM Anderson, B Tang, F Vaida, D Mcclernon, R Deutsch, M Cherner, D Cookson, M Crescini, I Grant, RJ Ellis, SL Letendre
Journal of acquired immune deficiency syndromes (1999) 2021
Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era
AM Anderson, Q Ma, SL Letendre, J Iudicello
Current HIV/AIDS Reports 2021
Central Nervous System Effects of COVID-19 in People with HIV Infection
MJ Peluso, J Hellmuth, FC Chow
Current HIV/AIDS Reports 2021
Immunotherapeutics to Treat HIV in the Central Nervous System
A Kapoor, CS Tan
Current HIV/AIDS Reports 2020
The Brain Retains: Nonhuman Primate Models for Pediatric HIV-1 in the CNS
V Obregon-Perko, K Bricker, A Chahroudi
Current HIV/AIDS Reports 2020
Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection
FJ Mahmud, Y Du, E Greif, T Boucher, RF Dannals, WB Mathews, MG Pomper, P Sysa-Shah, KA Pate, C Lyons, B Carlson, M Chacona, AM Brown
Journal of Neuroinflammation 2020
Interactions of Monocytes, HIV, and ART Identified by an Innovative scRNAseq Pipeline: Pathways to Reservoirs and HIV-Associated Comorbidities
R León-Rivera, B Morsey, M Niu, HS Fox, JW Berman, BD Walker, SP Goff
mBio 2020
Pharmacologic approaches to HIV-associated neurocognitive disorders
SN Avedissian, SR Dyavar, HS Fox, CV Fletcher
Current Opinion in Pharmacology 2020
New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment
Thomas A Angelovich, Melissa J Churchill, Edwina J Wright, Bruce J Brew
Current Topics in Behavioral Neurosciences 2020
The far-reaching HAND of cART: cART effects on astrocytes
H Gonzalez, A Podany, L Al-Harthi, J Wallace
Journal of Neuroimmune Pharmacology 2020
HIV Nef and Antiretroviral Therapy Have an Inhibitory Effect on Autophagy in Human Astrocytes that May Contribute to HIV-Associated Neurocognitive Disorders
L Cheney, H Guzik, FP Macaluso, F Macian, AM Cuervo, JW Berman
Cells 2020
Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies
JC McArthur, TP Johnson
Current Opinion in Neurology 2020
Effects of HIV gp120 on Neuroinflammation in Immunodeficient vs. Immunocompetent States
TJ Arabatzis, AA Wakley, VD McLane, D Canonico, L Cao
Journal of Neuroimmune Pharmacology 2020
Machine learning analysis reveals novel neuroimaging and clinical signatures of frailty in HIV
RH Paul, KS Cho, PM Luckett, JF Strain, AC Belden, JD Bolzenius, J Navid, PM Garcia-Egan, SA Cooley, JK Wisch, AH Boerwinkle, D Tomov, A Obosi, JA Mannarino, BM Ances
Journal of acquired immune deficiency syndromes (1999) 2020
Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system
D Gabuzda, JC McArthur, SL Letendre
AIDS 2020
Comparison of [11C]-PBR28 binding between persons living with HIV and HIV uninfected individuals
AH Boerwinkle, JF Strain, T Burdo, J Doyle, J Christensen, Y Su, JK Wisch, SA Cooley, F Vaida, MD Smith, H Jafri, RH Paul, TL Benzinger, BM Ances
Journal of acquired immune deficiency syndromes (1999) 2020
Is successful HIV therapy a Pyrrhic victory for the brain?
David Clifford
Journal of Clinical Investigation 2019
Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
JL Jacobs, EK Halvas, MA Tosiano, JW Mellors
Frontiers in microbiology 2019
Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults
SM Matt, PJ Gaskill
Brain Research 2019
Markers of CNS Injury in Adults Living With HIV With CSF HIV Not Detected vs Detected <20 Copies/mL
SF Farhadian, H Mistry, T Kirchwey, J Chiarella, R Calvi, M Chintanaphol, P Patel, ML Landry, K Robertson, SS Spudich
Open Forum Infectious Diseases 2019
Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV
JJ Kim-Chang, K Donovan, MS Loop, S Hong, B Fischer, G Venturi, PA Garvie, J Kohn, HJ Rendina, SP Woods, MM Goodenow, SL Nichols, JW Sleasman
AIDS 2019

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 26 news outlets
Blogged by 4
Posted by 20 X users
On 2 Facebook pages
Highlighted by 1 platforms
98 readers on Mendeley
See more details